TURTLE CAMERON (Chief Executive Officer) sold 2.2% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $492.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/4/2026ACC: 0001758363-26-000005
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$492.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−957.00
Price / share
$31.82
Trade value
$30.45K
% of position
0.1%
2/2/2026
672.54K→671.58K
Common Stock
Direct
Shares
−14.04K
Price / share
$32.87
Trade value
$461.59K
% of position
2.1%
2/2/2026
671.58K→657.54K
Total
Net shares
−15K
Net value
-$492.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −957.00 | $31.82 | $30.45K | 0.1% | 672.54K | 671.58K |
| Common Stock Direct | 2/2/2026 | S · Sale | −14.04K | $32.87 | $461.59K | 2.1% | 671.58K | 657.54K |
| Total | −15K | -$492.05K | ||||||
Derivative Transactions0
No derivative transactions reported